Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GBA1 | P04062 | 2/20 | 0.39 |
| ▸ | GLA | P06280 | 2/20 | 0.39 |
| ▸ | FUCA1 | P04066 | 2/20 | 0.39 |
| ▸ | GLB1 | P16278 | 2/20 | 0.39 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.32 |
| ▸ | LMNA | P02545 | 2/20 | 0.32 |
| ▸ | GAA | P10253 | 1/20 | 0.32 |
| ▸ | APP | P05067 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10038592 | 1.00 | GBA1 (0.39) | GBA1GLAFUCA1GLB1CYP2C9 | |
| SCHEMBL19228704 | 1.00 | GBA1 (0.39) | GBA1GLAFUCA1GLB1CYP2C9 | |
| SCHEMBL14153817 | 1.00 | GBA1 (0.39) | GBA1GLAFUCA1GLB1CYP2C9 | |
| SCHEMBL22196099 | 1.00 | GBA1 (0.39) | GBA1GLAFUCA1GLB1CYP2C9 | |
| SCHEMBL18965309 | 1.00 | GBA1 (0.39) | GBA1GLAFUCA1GLB1CYP2C9 | |
| SCHEMBL24268893 | 1.00 | GBA1 (0.39) | GBA1GLAFUCA1GLB1CYP2C9 | |
| SCHEMBL1964139 | 1.00 | GBA1 (0.39) | GBA1GLAFUCA1GLB1CYP2C9 | |
| SCHEMBL16760811 | 0.96 | GBA1 (0.37) | GBA1GLAFUCA1GLB1CYP2C9 | |
| SCHEMBL20691251 | 0.93 | FUCA1 (0.35) | GBA1GLAFUCA1GLB1GAA | |
| SCHEMBL15484275 | 0.92 | FUCA1 (0.39) | GBA1GLAFUCA1GLB1CYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2011073492-A1 | DERIVATIVES OF AMINOCYCLITOLS, OBTAINMENT PROCEDURE AND USES | CONSEJO SUPERIOR DE INVESTIGACIONES CIENTÍFICAS (CSIC) (ES) | 2011-06-23 | — | — | WO | disclosed |